Home / Cyclophosphamide / Czechia
CZ ATC L01AA01 · updated 2 Nov 2026
Cyclophosphamide shortage in Czechia
Is there a Cyclophosphamide shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Cyclophosphamide products are reported short in Czechia, the first since 30 Mar 2026. The company estimate for the return is 31 Dec 2026. Main reason: manufacturing problem.
Also short in Canada, Germany, France, Italy, Spain, Austria, Belgium, Switzerland, Sweden, Japan, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | ENDOXAN 200MG 200MG INJ/INF PLV SOL 10X1 | BAXTER CZECH spol. s r.o., Praha | 30 Mar 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | ENDOXAN 500MG 500MG INJ/INF PLV SOL 1 | BAXTER CZECH spol. s r.o., Praha | 30 Mar 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.